Sort
64,565 grants matching “drug discovery”
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
$778,890Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$778,810Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Glutamatergic adaptation to stress as a mechanism for anhedonia and treatment response with ketamine
$778,800Michael Tilghman Treadway · Emory University · R01 · FY2022 · MH
Histone Methyltransferases as a Target for Lung Cancer Prevention
$778,686Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2017 · CA
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
$778,536Joseph A Duncan · Univ Of North Carolina Chapel Hill · U01 · FY2024 · AI
Visant-Predictome: A System for Integration, Mining, Visualization and Analysis
$778,477Charles Delisi · Boston University (Charles River Campus) · R01 · FY2012 · GM
Small Molecule Mitochondria-Targeted Therapeutics for AD
$778,431Eugenia Trushina · Mayo Clinic Rochester · UH3 · FY2022 · NS
T Cell Alternative p38 Activation Pathway
$778,421Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
EDGE: Genetic transformation of chytrid fungi
$778,390Lillian K Fritz-Laylin · University Of Massachusetts Amherst · · FY2018 · BIO
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$778,372Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Epoch Telemetry System for Long-Term Monitoring of Biopotentials
$778,332Mark J. Lehmkuhle · Epitel, Inc. · R44 · FY2016 · NS
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Benjamin Solomon Freedman · University Of Washington · UH3 · FY2024 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Jonathan Himmelfarb · University Of Washington · UH3 · FY2023 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Jonathan Himmelfarb · University Of Washington · UH3 · FY2022 · TR
Understanding Sarcoidosis Susceptibility and Disease Burden Through Multi Omics
$778,266Courtney Montgomery · Oklahoma Medical Research Foundation · R01 · FY2025 · HL
Translation of GluN2B-selective PET radiopharmaceuticals in Alzheimers patients
$778,137Steven H Liang · Emory University · R01 · FY2024 · AG
Project 1: Structure, function, and inhibition of SEDS-family peptidoglycan polymerases
$778,131Andrew Kruse · Harvard Medical School · U19 · FY2025 · AI
Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor
$778,104Maria Ines Morano · Cayman Chemical Company, Inc. · R44 · FY2020 · AG
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$778,084Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2010 · RR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$778,084Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2010 · RR
Precision Phenomics to Personalize Drug Therapy (P3DT)
$777,951Joshua C. Denny · Vanderbilt University Medical Center · P50 · FY2016 · GM
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease
$777,939Li Shen · University Of Pennsylvania · R01 · FY2022 · AG
Scalable, all-optical assays of synaptic function and plasticity
$777,880Graham Thomas Dempsey · Q-State Biosciences, Inc. · R44 · FY2019 · MH
Genomics
$777,797John Robert Yates · Scripps Research Institute, The · U19 · FY2015 · AI
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
$777,716L. Elliot Hong · University Of Maryland Baltimore · P50 · FY2023 · MH